Prestige Consumer (PBH) Director Dawn M. Zier Receives Award

What Happened Dawn M. Zier, a director of Prestige Consumer Healthcare, was granted 2,981 restricted stock units (RSUs) on August 4, 2026, as part of the issuer's director compensation program. The grant is reported at a $0.00 acquisition price (typical for awards) and equals approximately $155,000 based on the closing stock price of $52.00 on the grant date. These RSUs will convert to one share of common stock per vested unit when settled.

Key Details

• Transaction date: August 4, 2026; Form 4 filed August 5, 2026 (timely filing).
• Grant: 2,981 RSUs; reported acquisition price $0.00; grant value ≈ $155,000 (based on $52.00 closing price).
• Vesting/settlement: RSUs vest on the first anniversary of the grant and will be settled by delivery of one share per vested RSU upon the earliest of (1) death, (2) separation, or (3) change in control.
• Shares owned after transaction: not specified in the filing.
• Footnote: Award issued under the issuer’s director compensation program; no 10b5-1 or tax-withholding codes reported.

Context This is a compensation grant to a non-employee director, a routine practice for aligning director interests with shareholders. Unlike an open-market purchase or sale, an RSU grant is not a direct bullish or bearish trading signal until/if the director retains or sells the shares after vesting.